Cargando…

Discovery of a novel integron-borne aminoglycoside resistance gene present in clinical pathogens by screening environmental bacterial communities

BACKGROUND: New antibiotic resistance determinants are generally discovered too late, long after they have irreversibly emerged in pathogens and spread widely. Early discovery of resistance genes, before or soon after their transfer to pathogens could allow more effective measures to monitor and red...

Descripción completa

Detalles Bibliográficos
Autores principales: Böhm, Maria-Elisabeth, Razavi, Mohammad, Marathe, Nachiket P., Flach, Carl-Fredrik, Larsson, D. G. Joakim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085159/
https://www.ncbi.nlm.nih.gov/pubmed/32197644
http://dx.doi.org/10.1186/s40168-020-00814-z
_version_ 1783508888012718080
author Böhm, Maria-Elisabeth
Razavi, Mohammad
Marathe, Nachiket P.
Flach, Carl-Fredrik
Larsson, D. G. Joakim
author_facet Böhm, Maria-Elisabeth
Razavi, Mohammad
Marathe, Nachiket P.
Flach, Carl-Fredrik
Larsson, D. G. Joakim
author_sort Böhm, Maria-Elisabeth
collection PubMed
description BACKGROUND: New antibiotic resistance determinants are generally discovered too late, long after they have irreversibly emerged in pathogens and spread widely. Early discovery of resistance genes, before or soon after their transfer to pathogens could allow more effective measures to monitor and reduce spread, and facilitate genetics-based diagnostics. RESULTS: We modified a functional metagenomics approach followed by in silico filtering of known resistance genes to discover novel, mobilised resistance genes in class 1 integrons in wastewater-impacted environments. We identified an integron-borne gene cassette encoding a protein that conveys high-level resistance against aminoglycosides with a garosamine moiety when expressed in E. coli. The gene is named gar (garosamine-specific aminoglycoside resistance) after its specificity. It contains none of the functional domains of known aminoglycoside modifying enzymes, but bears characteristics of a kinase. By searching public databases, we found that the gene occurs in three sequenced, multi-resistant clinical isolates (two Pseudomonas aeruginosa and one Luteimonas sp.) from Italy and China, respectively, as well as in two food-borne Salmonella enterica isolates from the USA. In all cases, gar has escaped discovery until now. CONCLUSION: To the best of our knowledge, this is the first time a novel resistance gene, present in clinical isolates, has been discovered by exploring the environmental microbiome. The gar gene has spread horizontally to different species on at least three continents, further limiting treatment options for bacterial infections. Its specificity to garosamine-containing aminoglycosides may reduce the usefulness of the newest semisynthetic aminoglycoside plazomicin, which is designed to avoid common aminoglycoside resistance mechanisms. Since the gene appears to be not yet common in the clinics, the data presented here enables early surveillance and maybe even mitigation of its spread.
format Online
Article
Text
id pubmed-7085159
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-70851592020-03-23 Discovery of a novel integron-borne aminoglycoside resistance gene present in clinical pathogens by screening environmental bacterial communities Böhm, Maria-Elisabeth Razavi, Mohammad Marathe, Nachiket P. Flach, Carl-Fredrik Larsson, D. G. Joakim Microbiome Research BACKGROUND: New antibiotic resistance determinants are generally discovered too late, long after they have irreversibly emerged in pathogens and spread widely. Early discovery of resistance genes, before or soon after their transfer to pathogens could allow more effective measures to monitor and reduce spread, and facilitate genetics-based diagnostics. RESULTS: We modified a functional metagenomics approach followed by in silico filtering of known resistance genes to discover novel, mobilised resistance genes in class 1 integrons in wastewater-impacted environments. We identified an integron-borne gene cassette encoding a protein that conveys high-level resistance against aminoglycosides with a garosamine moiety when expressed in E. coli. The gene is named gar (garosamine-specific aminoglycoside resistance) after its specificity. It contains none of the functional domains of known aminoglycoside modifying enzymes, but bears characteristics of a kinase. By searching public databases, we found that the gene occurs in three sequenced, multi-resistant clinical isolates (two Pseudomonas aeruginosa and one Luteimonas sp.) from Italy and China, respectively, as well as in two food-borne Salmonella enterica isolates from the USA. In all cases, gar has escaped discovery until now. CONCLUSION: To the best of our knowledge, this is the first time a novel resistance gene, present in clinical isolates, has been discovered by exploring the environmental microbiome. The gar gene has spread horizontally to different species on at least three continents, further limiting treatment options for bacterial infections. Its specificity to garosamine-containing aminoglycosides may reduce the usefulness of the newest semisynthetic aminoglycoside plazomicin, which is designed to avoid common aminoglycoside resistance mechanisms. Since the gene appears to be not yet common in the clinics, the data presented here enables early surveillance and maybe even mitigation of its spread. BioMed Central 2020-03-20 /pmc/articles/PMC7085159/ /pubmed/32197644 http://dx.doi.org/10.1186/s40168-020-00814-z Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Böhm, Maria-Elisabeth
Razavi, Mohammad
Marathe, Nachiket P.
Flach, Carl-Fredrik
Larsson, D. G. Joakim
Discovery of a novel integron-borne aminoglycoside resistance gene present in clinical pathogens by screening environmental bacterial communities
title Discovery of a novel integron-borne aminoglycoside resistance gene present in clinical pathogens by screening environmental bacterial communities
title_full Discovery of a novel integron-borne aminoglycoside resistance gene present in clinical pathogens by screening environmental bacterial communities
title_fullStr Discovery of a novel integron-borne aminoglycoside resistance gene present in clinical pathogens by screening environmental bacterial communities
title_full_unstemmed Discovery of a novel integron-borne aminoglycoside resistance gene present in clinical pathogens by screening environmental bacterial communities
title_short Discovery of a novel integron-borne aminoglycoside resistance gene present in clinical pathogens by screening environmental bacterial communities
title_sort discovery of a novel integron-borne aminoglycoside resistance gene present in clinical pathogens by screening environmental bacterial communities
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085159/
https://www.ncbi.nlm.nih.gov/pubmed/32197644
http://dx.doi.org/10.1186/s40168-020-00814-z
work_keys_str_mv AT bohmmariaelisabeth discoveryofanovelintegronborneaminoglycosideresistancegenepresentinclinicalpathogensbyscreeningenvironmentalbacterialcommunities
AT razavimohammad discoveryofanovelintegronborneaminoglycosideresistancegenepresentinclinicalpathogensbyscreeningenvironmentalbacterialcommunities
AT marathenachiketp discoveryofanovelintegronborneaminoglycosideresistancegenepresentinclinicalpathogensbyscreeningenvironmentalbacterialcommunities
AT flachcarlfredrik discoveryofanovelintegronborneaminoglycosideresistancegenepresentinclinicalpathogensbyscreeningenvironmentalbacterialcommunities
AT larssondgjoakim discoveryofanovelintegronborneaminoglycosideresistancegenepresentinclinicalpathogensbyscreeningenvironmentalbacterialcommunities